The results of the PPI network analysis suggested that AKT1, IL6, and IL1B could be potential core targets for treating DVT with HQGZWWD; IL-1B and IL-6 are proinflammatory cytokines with a wide range of biological activities [43]. This evidence concerns the gene IL1B and deep vein thrombosis.